Blood Testing Market to Reach USD 148 Billion by 2030, Growing at a 7% CAGR
According to Next Move Strategy Consulting, the global blood testing market, is forecast to reach USD 148 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7% by 2030. This market growth is driven by a combination of rising disease incidence, technological advancements, and increasing global awareness regarding the need for safe and effective blood transfusions.
Download Free Sample: https://www.nextmsc.com/blood-testing-market/request-sample
Market Insights
Blood tests are essential diagnostic tools used to analyze various substances in the blood, aiding in the detection and monitoring of numerous diseases. The most commonly performed blood test is the Complete Blood Count (CBC), which measures critical components like red and white blood cells, platelets, and hemoglobin. Blood tests are indispensable in identifying conditions such as anemia, infections, leukemia, HIV, and liver diseases.
The market is benefiting from a surge in blood testing requirements due to the increasing incidence of diseases, including thyroid disorders, hepatitis, and viral infections. Notably, initiatives like Global Blood Donor Day, celebrated on June 14th every year, highlight the importance of safe blood donations for transfusion, further propelling market growth.
Key Market Drivers
The rise in demand for blood testing can be attributed to several factors:
- Prevalence of Chronic and Infectious Diseases: The rise in diseases like HIV, genetic disorders, and hepatitis continues to drive the need for blood diagnostics.
- Awareness Campaigns: Governments and international organizations, including the United Nations and the World Health Organization (WHO), have heightened awareness about safe blood transfusions.
- Technological Innovation: Advances in blood testing technologies, such as glucometers with wireless connectivity and Bluetooth capabilities, contribute significantly to market expansion. Home diagnostic tests and self-testing kits like Omega-3 Index are further boosting the market.
Despite these positive trends, the market faces challenges such as the high cost of automated testing systems and a lack of awareness about new technologies. However, with rising adoption of new tools and innovations in testing devices, substantial opportunities for growth lie ahead.
Inquire Before Buying: https://www.nextmsc.com/blood-testing-market/inquire-before-buying
Market Segmentation
The global blood testing market is segmented by:
- Test Type: Includes Lipid, A1C, CRP, Vitamin D, Glucose, ALT, AST, and more.
- Products & Services: Comprising reagents & kits, instruments, and software & services.
- Technology: Nucleic acid testing, western blot assays, and next-generation sequencing.
- Method: Automated and manual testing methods.
- Disease: Anemia, infection, leukemia, among others.
- End User: Includes hospitals, diagnostic centers, clinics, and research labs.
- Region: North America, Europe, Asia-Pacific, and the Rest of the World.
Geographical Outlook
- North America continues to lead the global blood testing market, driven by high disease prevalence, especially blood cancers like leukemia. With increasing demand for blood in complex surgeries, North America is expected to maintain its dominance.
- Asia-Pacific is poised for rapid growth, fueled by rising diabetes cases and initiatives like the introduction of Nucleic Acid Testing (NAT) in India, which aids in detecting diseases like HIV and Hepatitis C. This region’s high population and expanding healthcare infrastructure are major drivers of the market.
Competitive Landscape
The blood testing market is highly competitive, with key players such as Siemens Healthcare, Abbott Laboratories, Thermo Fisher Scientific, BioMerieux S.A., and Cardinal Health dominating the space. Companies are investing in expanding their portfolios and strengthening regional presence.
For example, Abbott's recent FDA clearance of a traumatic brain injury blood test in March 2023 is a significant innovation in diagnostic testing. Similarly, Siemens Healthineers’ expansion of its Ottawa facility in June 2021 for the epoc Blood Analysis System represents a move to enhance point-of-care testing.
Conclusion
The global blood testing market is on a strong growth trajectory, with advancements in technology and rising demand for diagnostics across various diseases. This expansion is further fueled by growing awareness and initiatives aimed at improving public health. Despite challenges related to cost and technological awareness, the market presents vast opportunities for innovation and development.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.